Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 6/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.34 |
| ▸ | ACHE | P22303 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL452716 | 0.90 | ALDH1A1 (0.41) | CHRM1CHRM3CHRM5CHRM4CHRM2 | |
| SCHEMBL3447567 | 0.85 | THRB (0.49) | CHRM1CHRM3CHRM5MAPTBLM | |
| SCHEMBL8733322 | 0.80 | CHRM5 (0.55) | CHRM1CHRM3CHRM5MAPTBLM | |
| SCHEMBL3092716 | 0.80 | ALDH1A1 (0.46) | CHRM1CHRM3CHRM5MAPTBLM | |
| SCHEMBL2988331 | 0.78 | TSHR (0.57) | CHRM1CHRM3CHRM5MAPTBLM | |
| SCHEMBL57345 | 0.75 | THRB (0.50) | ACHELMNATHRBTSHR | |
| SCHEMBL9646938 | 0.72 | TSHR (0.55) | ACHEAPEX1THRBTSHR | |
| SCHEMBL3478021 | 0.72 | TSHR (0.45) | CHRM1SMN1; SMN2LMNATHRBTSHR | |
| SCHEMBL19456885 | 0.72 | TSHR (0.50) | ACHEAPEX1THRBTSHR | |
| SCHEMBL5709205 | 0.71 | TSHR (0.46) | ACHEAPEX1THRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6391292-B1 | COMPOSITIONS FOR FORM RETENTION OF AND/OR FIXING HAIRSTYLE WHICH PROVIDE HAIR WITH GOOD COSMETIC PROPERTIES, IN PARTICULAR GOOD DISENTANGLING, SOFTNESS AND PLEASANT APPEARANCE, IN ADDITION TO FIXING WHICH LASTS | L'ORéAL S.A. (FR) | 2002-05-21 | — | — | US | claimed |
| CN-101015511-B | Cosmetic composition, cosmetic process and use of the composition | OU LAIYA | 2012-11-21 | — | — | CN | disclosed |
| CN-101015511-A | Cosmetic composition, cosmetic process and use of the composition | OREAL (FR) | 2007-08-15 | — | — | CN | disclosed |
| US-7151079-B2 | Cosmetic compositions containing a fructan, a polysaccharide and a beneficial agent, and uses thereof | L'OREAL (FR) | 2006-12-19 | — | — | US | disclosed |
| US-20040106529-A1 | Cosmetic compositions containing a fructan, a polysaccharide and a benefical agent, and uses thereof | L'OREAL (FR) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106529-A1 | Cosmetic compositions containing a fructan, a polysaccharide and a benefical agent, and uses thereof | DSG1, CUTA, SHH | CHRM1 2449/4885CHRM3 2802/4885CHRM5 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.